Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa open-label study of injectable mouse nerve growth factor for diabetic foot ulcers
CTR20171634Phase 2Suspended
- Sponsor
- Sinobioway Bio-medicine
- Start
- Jan 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of mouse nerve growth factor in diabetic foot ulcer (DFU), sponsored by Sinobioway Bio-medicine. Started Jan 2018; status: suspended.
02
Drugs
mouse nerve growth factor
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on CTR20171634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171634.